CE Q1 2026 Earnings EPS Misses Estimates by 46 Stock Gains 107 FET Q1 2026 Earnings EPS Beats Estimates Amid Cost Discipline Stock Declines KROS Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Amid Pipeline Progress SOPH Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed PDS Biotechnology Q1 2026 Earnings EPS Beat on Narrower Loss Clinical Progress in Focus MGTX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline